Sarepta Therapeutics (SRPT) Current Leases (2022 - 2023)
Sarepta Therapeutics (SRPT) recorded quarterly Current Leases of $17.8 million in Q4 2023, up 15.21% quarter-over-quarter from $15.5 million in Q4 2022, and up 15.21% on a YoY basis from $15.5 million in Q4 2022.
Sarepta Therapeutics (SRPT) Current Leases (2022 - 2023) Analysis & Trends
Sarepta Therapeutics' Current Leases history runs 2 years deep, the most recent figure standing at $17.8 million for Q4 2023.
- In Q4 2023, Current Leases rose 15.21% year-over-year to $17.8 million; the TTM figure through Dec 2023 stood at $17.8 million (up 15.21% YoY), while the FY2023 annual figure was $17.8 million, up 15.21% from the prior year.
- Current Leases was $17.8 million for Q4 2023 at Sarepta Therapeutics, up from $15.5 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $17.8 million in Q4 2023 to a low of $15.5 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Sarepta Therapeutics | 1.84 Bn | 1.16 Bn | 291.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 17.85 Mn |
| Dec 31, 2022 | 15.49 Mn |